Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial - Concepedia

Concepedia

Publication | Closed Access

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

137

Citations

27

References

2019

Year

Adam L. Boxer, Irfan Qureshi, Michael K. Ahlijanian, Michael Grundman, Lawrence I. Golbe, Irene Litvan, Lawrence S. Honig, Paul Tuite, Nikolaus R. McFarland, Padraig O’Suilleabhain,

The Lancet Neurology

Dose Phase 1BTranslational MedicineClinical TrialsProgressive Supranuclear PalsyMedicineOrthopaedic Surgery

References

	Year	Citations

Page 1